Aehr Test Systems CEO sells 40,000 shares

Q: What insider transactions did AEHR (Aehr Test Systems) report in this Form 4?

The Form 4 reports that President and CEO Gayn Erickson sold 40,000 shares of Aehr Test Systems common stock on August 12, 2026 in two open-market transactions through a trust.

Q: How many AEHR shares did Gayn Erickson sell and at what prices?

Gayn Erickson sold 1,548 shares at $132.2674 per share and 38,452 shares at $130.7856 per share, all Aehr Test Systems common stock held indirectly through a trust.

Q: How many AEHR shares does Gayn Erickson hold after these transactions?

After the reported sales, Gayn Erickson is shown holding 197,521 AEHR shares directly. This amount includes shares subject to unvested restricted stock units and unvested restricted shares, according to the footnote.

Aehr Test Systems President and CEO Gayn Erickson reported two open-market sales of company common stock on August 12, 2026, totaling 40,000 shares held indirectly through a trust.

Filing Impact

(Neutral)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Aehr Test Systems President and CEO Gayn Erickson reported two open-market sales of company common stock on August 12, 2026, totaling 40,000 shares held indirectly through a trust. The filing also reports 197,521 shares held directly after the transactions, including shares subject to unvested restricted stock units and unvested restricted shares.

Insider Trade Summary

Net Seller: 40,000 shares

Net Sell 3 txns

Insider Erickson Gayn

Role President and CEO

Sold 40,000 shs ($5.23M)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,548	$132.2674	$205K
Sale	Common Stock	38,452	$130.7856	$5.03M
holding	Common Stock ^F1	--	--	--

Holdings After Transaction: Common Stock — 157,723 shares (Indirect, By Trust); Common Stock — 197,521 shares (Direct)

Footnotes (1)

F1. The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.

Key Figures

Shares sold (block 1): 1,548 shares at $132.2674 Shares sold (block 2): 38,452 shares at $130.7856 Total shares sold: 40,000 shares +1 more

4 metrics

Shares sold (block 1) 1,548 shares at $132.2674 Open-market sale of common stock on August 12, 2026, indirect by trust

Shares sold (block 2) 38,452 shares at $130.7856 Open-market sale of common stock on August 12, 2026, indirect by trust

Total shares sold 40,000 shares Aggregate non-derivative sales reported in the transaction summary

Direct holdings after transaction 197,521 shares Directly held common shares after transactions, including unvested RSUs and unvested restricted shares

Key Terms

indirect, By Trust, restricted stock units, unvested restricted shares

4 terms

indirect financial

"The 40,000 shares sold were reported as held indirectly, with the nature"

By Trust financial

"nature of ownership described as "By Trust", indicating the transactions"

restricted stock units financial

"includes shares subject to unvested restricted stock units and unvested"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

unvested restricted shares financial

"subject to unvested restricted stock units and unvested restricted shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AEHR (Aehr Test Systems) report in this Form 4?

The Form 4 reports that President and CEO Gayn Erickson sold 40,000 shares of Aehr Test Systems common stock on August 12, 2026 in two open-market transactions through a trust.

How many AEHR shares did Gayn Erickson sell and at what prices?

Gayn Erickson sold 1,548 shares at $132.2674 per share and 38,452 shares at $130.7856 per share, all Aehr Test Systems common stock held indirectly through a trust.

Were the AEHR shares sold by Gayn Erickson held directly or indirectly?

The 40,000 Aehr Test Systems shares sold were reported as held indirectly, with the nature of ownership described as "By Trust", indicating the transactions involved shares held through a trust.

How many AEHR shares does Gayn Erickson hold after these transactions?

After the reported sales, Gayn Erickson is shown holding 197,521 AEHR shares directly. This amount includes shares subject to unvested restricted stock units and unvested restricted shares, according to the footnote.

Does this AEHR Form 4 show any derivative securities or option exercises?

No derivative transactions or option exercises are reported. The filing’s transaction summary shows two non-derivative sales totaling 40,000 shares and no derivative transactions in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/13/2026 - 06:12 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Erickson Gayn

(Last)

(First)

(Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT

CALIFORNIA

94539

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/12/2026		S		1,548	D	$132.2674	196,175	I	By Trust
Common Stock	08/12/2026		S		38,452	D	$130.7856	157,723	I	By Trust
Common Stock								197,521⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR